Earnings History Data for NGM Biopharmaceuticals, Inc. (NGM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals Inc. is focused on developing novel therapeutics for underlying cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's product pipeline consists of NGM282, NGM313, NGM120, NGM217, NGM621, NGM386 and NGM395 which are in clinical stage. NGM Biopharmaceuticals Inc. is based in San Francisco, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-03-2024	AH		NGM	NGM Biopharmaceuticals	127.00	-0.33	-0.37	0.00	NGM Biopharmaceuticals GAAP EPS of -$0.33 misses by $0.01 [3/11/2024 5:09 PM]	1.53	-0.01 (-0.65%)	1.53	-0.01 (-0.65%)	0.60 - 4.69	774,724	1,310,000	59,442
NGM Biopharmaceuticals GAAP EPS of -$0.33 misses by $0.01 [3/11/2024 5:09 PM]
28-02-2023	AH		NGM	NGM Biopharmaceuticals	375.00	-0.45	-0.52	0.00	NGM Biopharmaceuticals GAAP EPS of -$0.45 beats by $0.07, revenue of $18.18M beats by $11.56M [2/28/2023 5:39 PM]	4.68	-0.06 (-1.16%)	4.77	0.03 (0.63%)	2.92 - 18.25	200,504	300,000	22,440
NGM Biopharmaceuticals GAAP EPS of -$0.45 beats by $0.07, revenue of $18.18M beats by $11.56M [2/28/2023 5:39 PM]
01-03-2022	AH		NGM	NGM Biopharmaceuticals	1,172	-0.35	-0.37	0.00	NGM Biopharmaceuticals GAAP EPS of -$0.35 beats by $0.01, revenue of $20.96M beats by $0.76M [3/1/2022 4:55 PM]	16.18	1.70 (11.74%)	14.48	0.0 (0.00%)	13.73 - 32.12	228,940	120,000	5,201
NGM Biopharmaceuticals GAAP EPS of -$0.35 beats by $0.01, revenue of $20.96M beats by $0.76M [3/1/2022 4:55 PM] NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-01-22 04:06PM] Intra-Cellular Therapies (ITCI) Reports Q4 Loss, Tops Revenue Estimates [Mar-01-22 08:55AM] NGM Bio to Participate in the Cowen 42nd Annual Health Care Conference [Feb-28-22 08:00AM] NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Tops Revenue Estimates [Mar-01-22 05:25PM]
04-11-2021	AH	4:05 PM ET (Nov 4)	NGM	NGM Biopharmaceuticals	1,480	-0.37	-0.38	0.00	NGM Biopharmaceuticals EPS beats by $0.01, misses on revenue [11/4/2021 5:10 PM]	21.53	1.42 (7.06%)	20.11	0.0 (0.00%)	14.90 - 32.12	483,056	230,000	2,277
NGM Biopharmaceuticals EPS beats by $0.01, misses on revenue [11/4/2021 5:10 PM] NGM Bio Provides Business Highlights and Reports Third Quarter 2021 Financial Results [Nov-04-21 04:05PM] NGM Biopharmaceuticals (NGM) May Report Negative Earnings: Know the Trend Ahead of Q3 Release [Nov-04-21 03:01PM] NGM Biopharmaceuticals (NGM) Reports Q3 Loss, Lags Revenue Estimates [Nov-04-21 06:45PM]
05-08-2021	AH	4:05 PM ET (Aug 5)	NGM	Ngm Biopharmaceuticals, Inc.	1,552	-0.48	-0.39	0.00	NGM Biopharmaceuticals EPS misses by $0.10, misses on revenue [8/5/2021 5:18 PM]	25.44	2.40 (10.42%)	22.39	-0.65 (-2.82%)	14.90 - 32.12	494,722	420,000	410
NGM Bio Provides Business Highlights and Reports Second Quarter 2021 Financial Results [Aug-05-21 04:05PM] NGM Biopharmaceuticals (NGM) Expected to Beat Earnings Estimates: Should You Buy? [Aug-04-21 03:00PM] NGM Biopharmaceuticals (NGM) Reports Q2 Loss, Lags Revenue Estimates [Aug-05-21 07:05PM]
06-05-2021	AH	4:05 PM ET (May 6)	NGM	Ngm Biopharmaceuticals, Inc.	2,090	-0.36	-0.42	0.00	NGM Biopharmaceuticals EPS beats by $0.05, misses on revenue [5/6/2021 5:09 PM]	26.77	0.02 (0.07%)	26.77	0.0 (0.00%)	14.93 - 32.12	70,745	120,000	1,301
NGM Biopharmaceuticals EPS beats by $0.05, misses on revenue [5/6/2021 5:09 PM] NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial Results [May-06-21 04:05PM] Earnings Preview: NGM Biopharmaceuticals (NGM) Q1 Earnings Expected to Decline [May-05-21 03:00PM] NGM Biopharmaceuticals (NGM) Reports Q1 Loss, Tops Revenue Estimates [May-06-21 07:55PM]